Correlation Between Bank of America and Integrated Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bank of America and Integrated Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Integrated Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and Integrated Biopharma, you can compare the effects of market volatilities on Bank of America and Integrated Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Integrated Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Integrated Biopharma.

Diversification Opportunities for Bank of America and Integrated Biopharma

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Bank and Integrated is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Integrated Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Biopharma and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Integrated Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Biopharma has no effect on the direction of Bank of America i.e., Bank of America and Integrated Biopharma go up and down completely randomly.

Pair Corralation between Bank of America and Integrated Biopharma

Considering the 90-day investment horizon Bank of America is expected to generate 0.35 times more return on investment than Integrated Biopharma. However, Bank of America is 2.85 times less risky than Integrated Biopharma. It trades about 0.11 of its potential returns per unit of risk. Integrated Biopharma is currently generating about -0.02 per unit of risk. If you would invest  2,583  in Bank of America on August 26, 2024 and sell it today you would earn a total of  2,117  from holding Bank of America or generate 81.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy13.96%
ValuesDaily Returns

Bank of America  vs.  Integrated Biopharma

 Performance 
       Timeline  
Bank of America 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bank of America are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Bank of America exhibited solid returns over the last few months and may actually be approaching a breakup point.
Integrated Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Integrated Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Integrated Biopharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Bank of America and Integrated Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bank of America and Integrated Biopharma

The main advantage of trading using opposite Bank of America and Integrated Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Integrated Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Biopharma will offset losses from the drop in Integrated Biopharma's long position.
The idea behind Bank of America and Integrated Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance